Global Health (MEDANTA) Share Price Falls 3.99% in Second Straight Session

Global Health Share Price has now closed lower for the second straight session, with the cumulative move across the streak at -3.99% from Rs 1,433.8 to Rs 1,376.6. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The latest reading also places the stock’s market capitalisation at Rs 38,551.27 crore, keeping Global Health Share Price firmly in the large-cap bracket.

For readers tracking Global Health Share Price Fall Streak, the important point is not just one lower session but the pattern of consecutive declines. A two-session run gives a wider view of how the stock has moved relative to its earlier base, even though the current figures alone do not identify a reason for the move. In the healthcare space, that makes Global Health Share Price relevant for both price action and fundamental analysis, especially as investors compare the move with valuation and sector benchmarks.

Global Health (MEDANTA) Share Price Fall Streak: Consecutive Decline Analysis

Metric	Value
Current Price	Rs 1,376.6
Previous Close	Rs 1,415.5
Today's Move	-Rs 38.90 (-2.75%)
Open	Rs 1,420.65
High	Rs 1,421.45
Low	Rs 1,364.3
Market Capitalisation	Rs 38,551.27 crore

Global Health Share Price was at Rs 1,376.6, compared with the previous close of Rs 1,415.5, leaving a decline of Rs 38.9 or 2.75% in the latest session. The stock opened at Rs 1,420.65, touched a high of Rs 1,421.45 and a low of Rs 1,364.3 before settling near the lower end of that range. That placement shows Global Health Share Price traded through a relatively wide band during the session and finished well below the opening level. The market capitalisation stood at Rs 38,551.27 crore, which keeps Global Health Share Price in the large-cap category. For traders and long-term readers alike, the main takeaway is the repeated lower close, which makes Global Health Share Price more than a single-day move and links the latest price action to the broader two-session streak. The next lens is the company’s fundamental profile.

What the Consecutive Declines Show

Global Health Share Price Fall Streak matters because the stock has moved lower for the second straight session, not just once. The cumulative decline of 3.99% from Rs 1,433.8 gives a clearer read on the streak than the daily move alone. For Global Health Share Price, the latest session also came after a start above Rs 1,420, which means the day’s trading did not reverse the earlier weakness. The pattern shows how consecutive lower closes can shift the discussion from a one-off price reaction to a more persistent stretch of weakness. According to Univest data, the price pattern is visible, but the figures do not establish a company-specific reason for the continued slide. That is why the next question is whether the underlying fundamentals and valuation now look different after the two-session move.

Global Health (MEDANTA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 38,551.27 crore
P/E Ratio	68.43x
P/B Ratio	9.26x
ROE	15.12%
ROCE	19.38%
EPS	Rs 20.69
Book Value Per Share	Rs 152.94
Dividend Yield	0.04%

Global Health has a market capitalisation of Rs 38,551.27 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 68.43x, P/B at 9.26x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 15.12% and ROCE of 19.38%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.69, book value per share of Rs 152.94, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 46.9x, median ROE of 13.01%, median ROCE of 15.84%. Taken together, they outline the fundamentals rather than a view on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Hospital & Healthcare Services
Benchmark Scope	same industry
Company P/E Ratio	68.43x
Benchmark Median P/E	46.9x
Benchmark Average P/E	100.02x
Benchmark P/E Range	6.8x to 1,572.9x
Company P/B Ratio	9.26x
Benchmark Median P/B	3.88x
Benchmark Average P/B	4.71x
Company ROE	15.12%
Benchmark Median ROE	13.01%
Benchmark Average ROE	12.87%
Company ROCE	19.38%
Benchmark Median ROCE	15.84%
Benchmark Average ROCE	2.83%
Company Market Capitalisation	Rs 38,551.27 crore
Benchmark Median Market Cap	Rs 578.29 crore
Benchmark Average Market Cap	Rs 11,352.34 crore

Global Health Share Price should be read against the healthcare sector and the hospital & healthcare services industry, where the benchmark scope covers 65 companies. On the Univest benchmark set, the company’s P/E of 68.43 is above the median of 46.9 and below the average of 100.02, while the company’s P/B of 9.26 is above the benchmark median of 3.88 and above the average of 4.71. That places Global Health Share Price at a richer valuation than the typical benchmark company on both measures. ROE of 15.12% is above the benchmark median of 13.01% and slightly above the average of 12.87%, while ROCE of 19.38% is above the benchmark median of 15.84% and well above the average of 2.83%. The sector data also show a wide market-cap spread, with the benchmark median at Rs 578.29 crore and the average at Rs 11,352.34 crore. Against that backdrop, Global Health Share Price remains in the large-cap end of the spectrum and still compares favourably on returns, even after the two-session fall. Sector positioning matters here because the latest decline has not changed the company’s relative benchmark standing.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Apollo Hospitals Enterprise	APOLLOHOSP	1,27,421.96	59.88	12.92	23.54	21.73
Max Healthcare Institute	MAXHEALTH	97,418.62	65.73	8.76	14.53	14.97
MANIPAL HEALTH ENTERPRI L	MANIPALHOS	94,970.23	110.4	5.4	12.95	13.93
Aster DM Healthcare	ASTERDM	65,183.66	201.12	15.15	13.07	16.22
Fortis Healthcare	FORTIS	62,782.32	59.01	6.08	11.32	14.07

Global Health Share Price can also be viewed alongside listed peers in the same industry. Apollo Hospitals Enterprise carries a market cap of Rs 1,27,421.96 crore, a P/E of 59.88, a P/B of 12.92, ROE of 23.54% and ROCE of 21.73%. Max Healthcare Institute shows Rs 97,418.62 crore, P/E of 65.73, P/B of 8.76, ROE of 14.53% and ROCE of 14.97%. Fortis Healthcare stands at Rs 62,782.32 crore, P/E of 59.01, P/B of 6.08, ROE of 11.32% and ROCE of 14.07%. On that set, Global Health Share Price sits below Apollo and Max on market cap, close to Max on valuation, and above Fortis on both return ratios. The streak has not changed the company’s relative position in a simple way, but it has made the valuation gap more visible after the lower sessions. For Global Health Share Price, the comparison suggests stronger returns than some peers, though not the highest in the group.

Why Investors Are Watching Global Health

• Global Health Share Price has now moved lower for the second straight session, which makes the streak more relevant than a one-day decline.
• The latest Global Health Share Price move came with a P/E of 68.43 and a P/B of 9.26, so valuation remains a central part of the discussion.
• ROE of 15.12% and ROCE of 19.38% keep Global Health Share Price in a comparatively strong return band versus the benchmark set.
• Global Health Share Price is still in the large-cap category, with market capitalisation at Rs 38,551.27 crore.
• Peer comparison shows Global Health Share Price trading in the same healthcare cluster as large listed hospital operators.

About Global Health

Global Health operates in the healthcare sector and the hospital & healthcare services industry. The business context matters because Global Health Share Price is tied to a service model that depends on healthcare delivery, patient flow and operating efficiency rather than commodity pricing. For readers assessing Global Health Share Price Fall Streak, the company profile is useful mainly as a backdrop to the valuation and return metrics. The latest Univest figures place the company among established healthcare names, and the market is currently pricing it on a higher earnings multiple than the benchmark median. That is why Global Health Share Price is being watched not only for the streak itself but also for how its earnings and book-value profile fits into the sector comparison.

Track Global Health Share Price on Univest

Use Global Health (MEDANTA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Readers can track Global Health Share Price on Univest for live price updates, fundamental ratios, market capitalisation, 52-week levels and sector insights. The same page also helps place Global Health Share Price in context with valuation, return ratios and peer comparison. For anyone following Global Health Share Price Fall Streak, that makes it easier to monitor the company’s latest stock performance alongside the broader healthcare benchmark.

Frequently Asked Questions

Why is Global Health Share Price falling today?

Ans. Global Health Share Price is lower in a second straight session, but the latest figures do not establish a company-specific catalyst. The move is confirmed through price action, not through a stated reason.

What is the current Global Health Share Price?

Ans. Global Health Share Price is Rs 1,376.6. It was down Rs 38.9, or 2.75%, from the previous close of Rs 1,415.5 in the latest session. The intraday range extended from Rs 1,364.3 to Rs 1,421.45.

How much has Global Health Share Price fallen across the streak?

Ans. Global Health Share Price has fallen 3.99% across the two-session streak. The move started from Rs 1,433.8, which helps show the cumulative decline rather than only the latest session.

Is Global Health a large-cap stock?

Ans. Yes. Global Health Share Price sits within the large-cap category, with market capitalisation at Rs 38,551.27 crore. That size context matters when reading the latest decline and peer comparison.

What do the valuation ratios say about Global Health Share Price?

Ans. Global Health Share Price is trading at a P/E of 68.43 and a P/B of 9.26. Those multiples sit above the benchmark median, which keeps valuation central to the discussion.

How do ROE and ROCE compare for Global Health ?

Ans. Global Health reports ROE of 15.12% and ROCE of 19.38%. Both are above the benchmark median in the same industry set, which helps frame the stock despite the recent decline.

How does Global Health Share Price compare with peers?

Ans. Global Health Share Price sits below Apollo Hospitals and Max Healthcare on market cap, but it remains in a stronger return band than Fortis on ROE and ROCE. The latest decline does not change that ranking.

What should investors monitor next in Global Health Share Price?

Ans. Investors can watch whether Global Health Share Price stabilises after the second straight lower close, while keeping an eye on valuation, peer positioning and the company’s return ratios. Those facts matter more than a single session alone.